Therapeutic Advances in Psychopharmacology

Papers
(The H4-Index of Therapeutic Advances in Psychopharmacology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?40
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications33
Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre–post observational study23
Clozapine discontinuation withdrawal symptoms in schizophrenia21
Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions21
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders20
Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies20
Transcranial magnetic stimulation for post-traumatic stress disorder19
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review17
The role of lumateperone in the treatment of schizophrenia17
Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data16
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review16
Cognitive effects of vortioxetine in older adults: a systematic review15
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review14
0.021634101867676